Clinic and wellness demand
Sermorelin is presented as one of the peptides with increased wellness-clinic demand, especially around muscle, aging, and energy narratives.
Geref · GRF 1-29
Popular for:Growth hormone stimulation, sleep quality, anti-aging
27
Registered Trials
0
Trial Publications
22
PubMed References
Approved
Evidence Level
Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), consisting of the first 29 amino acids of the 44-amino acid GHRH sequence. The short version: people usually care about it for growth hormone stimulation, sleep quality, anti-aging, but the strength of the evidence depends heavily on indication and study type.
Sermorelin is a synthetic analog of growth hormone-releasing hormone (GHRH), consisting of the first 29 amino acids of the 44-amino acid GHRH sequence. It was FDA-approved in 1997 as Geref for diagnostic evaluation of pituitary function and was used clinically for growth hormone deficiency in children.
Although the branded product was discontinued in 2008 due to manufacturing issues (not safety concerns), Sermorelin continues to be widely compounded and studied. It stimulates the pituitary to produce and release its own growth hormone, preserving the natural feedback loop.
Sermorelin currently shows 27 registered trials from ClinicalTrials.gov, 0 PubMed trial publications (0 RCT-tagged), and 22 PubMed references matching the stored source query. Treat PubMed references as literature surface area, not a count of clinical trials.
Known signals
Open questions
Sermorelin binds to GHRH receptors on somatotroph cells in the anterior pituitary, stimulating the synthesis and secretion of endogenous growth hormone.
Research Pipeline
27
Registered Trials
0
Trial Publications
0
RCT Publications
22
PubMed References
Registered trials are ClinicalTrials.gov intervention records. Trial publications are PubMed records tagged as clinical trials or randomized controlled trials. PubMed references are broader source-query matches and can include animal studies, in-vitro work, reviews, mechanism papers, and trial publications.
27
Registered trials
0
Trial publications
0
RCT publications
22
PubMed references
4
Reviews
0
Meta-analyses
Registered trials source
Jun 1, 2026
Sermorelin
Uses the exact compound name as a ClinicalTrials.gov intervention query.
View sourcePreviously FDA-approved (Geref, 1997). Branded product discontinued 2008 (manufacturing, not safety). Widely compounded. Potential Category 1 reinstatement under RFK announcement.
Rahman OF, Lee SJ, Seeds WA · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026
PMID: 41490200Mendias CL, Awan TM · Sports medicine (Auckland, N.Z.) · 2026
PMID: 41966639Uçaktürk E, Nemutlu E · Journal of pharmaceutical and biomedical analysis · 2026
PMID: 41138283Coutinho LFD, DE Oliveira Neves LF, Camilo RP · The Journal of sports medicine and physical fitness · 2026
PMID: 41880199Thomas A, Walpurgis K, Thevis M · Journal of mass spectrometry : JMS · 2024
PMID: 38197510This section summarizes what people are talking about in public sources. It can be useful for spotting questions, hype cycles, and recurring concerns, but it is separate from the evidence sections above.
Sermorelin is presented as one of the peptides with increased wellness-clinic demand, especially around muscle, aging, and energy narratives.
- Injection site reactions (redness, swelling) - Facial flushing - Headache - Dizziness or lightheadedness
No curated interaction entry is live for Sermorelin yet.
Until the interaction table is fully populated, use the interaction checker and related peptides below to explore adjacent compounds and likely research pairings.
This page is for research and educational purposes only. The information presented is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Regulatory status can vary by compound, formulation, indication, and jurisdiction. Check official labeling, registry records, and qualified professional guidance before making any health-related decision. The studies referenced are linked to their original PubMed sources for verification.